Getinge Interim Report January-September 2016
Third quarter of 2016 in brief · Order intake decreased 3.0% to SEK 7,176 M (7,397). The order intake declined organically by 3.2%. · Net sales increased 0.1% to SEK 6,929 M (6,925). Net sales increased organically by 0.2%. · Gross...
Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge
Getinge Group has recently performed a strategic review to clarify its long-term strategy for ensuring sustainable and profitable growth. Getinge will focus on two business areas, Acute Care Therapies and Surgical Workflows. In light of this, the...
Getinge Group announces date of Interim Report January-September 2016 and conference call
Getinge will issue its Interim Report for January-September 2016 on Tuesday October 18th at 13:00 CET, followed by a conference call at 15:00 CET, hosted by Joacim Lindoff, Acting President & CEO, and Reinhard Mayer, CFO. We invite fund...
Getinge Group appoints Reinhard Mayer as new CFO and Magnus Lundbäck as new Executive Vice President Human Resources & Sustainability
Getinge Group has appointed Reinhard Mayer as new CFO and Magnus Lundbäck as new Executive Vice President Human Resources & Sustainability. Reinhard most recently served as President Supply Chain and was the CFO of the Medical Systems business...
Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group
The Board of Directors of Getinge AB has decided to replace the President & CEO of the Getinge Group, which means that Getinges’ President & CEO Alex Myers is leaving his position. The Board of Directors has appointed Joacim Lindoff as Acting...
Getinge Interim Report January-June 2016
Second quarter of 2016 in brief · Order intake: -0.7% to SEK 7,460 M (7,516). The order intake grew organically by 3.0%. · Net sales: -3.5% to SEK 6,927 M (7,181). Net sales fell organically by 0.3%. · Gross margin: 45.7% (46.4)....
Getinge Group announces date of Interim Report January-June 2016 and conference call
Getinge will issue its Interim Report for January-June 2016 on Thursday July 14th at 08:00 CET, followed by a conference call at 10:00 CET, hosted by Alex Myers, President & CEO, and Pernille Fabricius, CFO. We invite fund managers, analysts...
Getinge Group appoints Jens Viebke as new President of Acute Care Therapies Business Category Unit
Getinge Group has appointed Jens Viebke as the new President of the Acute Care Therapies Business Category Unit. Jens will be a member of the Getinge Group Executive Team and succeeds Heinz Jacqui who will step down from his current position after...
Getinge Interim Report January-March 2016
First quarter of 2016 in brief · Order intake declined by 3.7% to SEK 6,924 M (7,192). The order intake declined organically by 2.0%. · Net sales fell by 5.0% to SEK 6,377 M (6,712). Net sales fell organically by 3.2%. · The gross...
Getinge announces date of 2016 Q1 report and conference call
Getinge will issue its Q1 report for 2016 on Friday April 22nd at 13:00 CET, followed by a conference call at 14:30 CET, hosted by Alex Myers, CEO, and Pernille Fabricius, CFO. We invite fund managers, analysts and the media to participate in...
Changes to Getinge Group’s financial reporting
As previously announced, Getinge introduced a new organizational structure effective January 1, 2016 that better reflects customer requirements and enables more effective governance of the Group. Consequently, a new financial governance model and...
Resolutions at Getinge’s Annual General Meeting
At the Annual General Meeting of Getinge AB held on 30 March 2016, the following was resolved. Election of Board of Directors Carl Bennet (Chairman), Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Alex Myers, Malin Persson, Johan Stern and...
Getinge publishes the Board’s proposal for resolution on the AGM 2016 regarding a long-term incentive program and the adopted performance condition
Today, Getinge publishes the Board’s complete proposal for resolution on the Annual General Meeting 2016 regarding implementation of a long-term incentive program (LTIP 2016). The proposal entails an amendment to the performance conditions...
Getinge Annual Report 2015
Getinge AB’s annual report for 2015 can now be found on the company website www.getingegroup.com. A printed version of the annual report will be distributed by mail to all shareholders who have given notice to the company that they wish to...
NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB
The shareholders of Getinge AB (publ) are hereby invited to attend the Annual General Meeting (“AGM”) to be held on Wednesday 30 March 2016 at 2.00 p.m. CET, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. RIGHT TO ATTEND Shareholders...
Getinge Group Year-End Report 2015
FOURTH QUARTER IN BRIEF · Order intake increased by 7.5% to SEK 8,326 M (7,747). Order intake grew organically by 1.2%. · Net sales increased by 11.3% to SEK 9,417 M (8,458). Net sales increased organically by 4.3%. · EBITA* fell...
Getinge announces date of 2015 Q4 report and conference call
Getinge will issue its Q4 report for 2015 on Thursday January 28th 2016 at 13:00 CET, followed by a conference call at 15:00 CET, hosted by Alex Myers, CEO, and Ulf Grunander, CFO. We invite fund managers, analysts and the media to participate...
Pernille Fabricius appointed new CFO of Getinge Group
Getinge Group has appointed Pernille Fabricius as new Chief Financial Officer of Getinge Group. Pernille will be part of the Getinge Executive Team and will succeed Ulf Grunander, who has decided to retire from his position after 23 years as CFO...
Getinge Infection Control enters into low temperature market with acquisition of Stericool and exclusive distribution agreement with TSO3
Getinge Group’s business area Infection Control, a global leader in infection control and contamination prevention solutions, has acquired Stericool, a Turkish company specializing in low temperature sterilization, and also signed an exclusive...
Getinge Group Interim Report January - September 2015
Third quarter in brief · Order intake increased by 15.3% to SEK 7,398 M (6,414), and grew organically by 5.2%. · Net sales rose by 11.2% to SEK 6,925 M (6,225). Net sales increased organically by 1.1%. · EBITA* declined by 10.0%...